Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

431 results about "Cyst" patented technology

An abnormal sac in the body filled with fluid or semisolid materials.

Preparation for repairing cartilage defects or cartilage/bone defects in human or animal joints

InactiveUS6858042B2Reduce absorptionResistant to resorptionBone implantJoint implantsRepair tissueCyst
Repairs of cartilage defects or of cartilage/bone defects in human or animal joints with the help of devices including a bone part (1), a cartilage layer (2) and a subchondral bone plate (4) or an imitation of such a plate in the transition region between the cartilage layer (2) and the bone part (1). After implantation, the bone part (4) is resorbed and is replaced by reparative tissue only after being essentially totally resorbed. In a critical phase of the healing process, a mechanically inferior cyst is located in the place of the implanted bone part (1). In order to prevent the cartilage layer (2) from sinking into the cyst space during this critical phase of the healing process the device has a top part (11) and a bottom part (12), wherein the top part (11) consists essentially of the cartilage layer (2) and the subchondral bone plate (4) and the bottom part (12) corresponds essentially to the bone part (1) and wherein the top part (11) parallel to the subchondral bone plate (4) has a larger diameter than the bottom part (12). After implantation in a suitable opening or bore (20), the cartilage layer (2) and the subchondral bone plate (4) are supported not only on the bone part (1) but also on native bone tissue having a loading capacity not changing during the healing process. Therefore, the implanted cartilage layer cannot sink during the healing process.
Owner:ZIMMER GMBH

Artificial crystalline len with transforming growth factor resistant beta2 antibody membrane on surface and manufacturing method thereof

ActiveCN101269240ANo toxicityToxic realizationCoatingsIntraocular lensPhosphateCyst
The invention provides an artificial lentis, which contains anti-transforming growth factor beta 2 antibody membrane on the surface and can inhibit intercurrent post-cataract after cataract surgery, and also provides a the production method thereof. The production method includes the steps that: the artificial lentis is charged with positive electricity or negative electricity after the artificial lentis is cleaned, dried, and pretreated on the surface; the artificial lentis is soaked in a polyelectrolyte solution the charge of which is opposite to the surface charge of the artificial lentis for adsorbing, and rinsing the artificial lentis by deionized water, and drying the artificial lentis by nitrogen gas; the artificial lentis is soaked in a phosphate buffering solution of anti-transforming growth factor beta 2 antibody, the pH value of which is 4-10, and the carried charge of which is opposite to that of the polyelectrolyte, for adsorption; finally, the artificial lentis is rinsed by phosphate buffering solution, and the artificial lentis is dried by nitrogen gas; the alternating assembly steps are repeated. The artificial lentis of the invention can inhibit the transformation and differentiation as well as cyst membrane shrinkage of the lentis epithelial cells in a target way, and then interdicts the occurrence of the post-cataract, and has excellent biocompatibility. The production method of the invention is scientific and simple, and can ensure the activity under a dry state and the safety and reliability during medical transplantation of the anti-transforming growth factor beta 2.
Owner:SECOND AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE

Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method

InactiveCN101711849AMental tension improvedMental failure improvedNervous disorderAnthropod material medical ingredientsSide effectCyst
The invention discloses a traditional Chinese medicine composition for treating the symptoms of qi stasis, blood stasis, myoma and cyst and a preparation method. The traditional Chinese medicine composition mainly comprises the following raw materials of medicines: tangerine peel, immature bitter orange, rosa banksiae, rhizoma cyperi, TurmericRoot-tuber, medicated leaven, Chinese eaglewood, radix linderae, toosendan fruit, fructus citri sarcodactylis, malt, hawthorn, rhizoma ligustici wallichii, radix salviae miltiorrhizae, peach kernel, safflower, rhizoma sparganii, rhizoma zedoariae, scaly anteater, carapax amydae, tortoise plastron, semen raphani, green tangerine peel, radix aristolochiae, longstamen onion bulb, citron, scorched areca, dried ginger, corydalis tuber, curcuma, trogopterus dung, motherwort, spatholobus stem, logwood, draconis sanguis, red peony root, white peony root, angelica and the like. The traditional Chinese medicine composition can be prepared into any common oral preparation according to a conventional traditional Chinese medicine preparation method. The invention can obviously improve the physical signs of the whole bodies of patients with the symptoms of qi stasis, blood stasis, myoma and cyst, regulates the viscera functions of the patients, regulates the circulation of the qi and the blood of an organism, removes the qi stasis and the blood stasis, eliminates lumps, calms down the stasis and has definite clinical curative effect, obvious curative effect and quick acting. As basically adopting medicine-food homologous medicines specified by the dispensatory of China for combination, the traditional Chinese medicine composition has the advantages of low cost, no toxic or side effect basically and the like.
Owner:TAIYI HEPU BEIJING RES INST OF TCM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products